Global and China Biosimilar Testing and Development Services Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2026
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2015-2026)
2.2 Global Biosimilar Testing and Development Services Growth Trends by Regions
2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Market Size
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2015-2020)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2015-2020)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2019
3.5 Key Players Biosimilar Testing and Development Services Area Served
3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.7 Date of Enter into Biosimilar Testing and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type (2015-2026)
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2015-2020)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2021-2026)
5 Biosimilar Testing and Development Services Breakdown Data by Application (2015-2026)
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2015-2020)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2015-2026)
6.2 North America Biosimilar Testing and Development Services Market Size by Type (2015-2020)
6.3 North America Biosimilar Testing and Development Services Market Size by Application (2015-2020)
6.4 North America Biosimilar Testing and Development Services Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2015-2026)
7.2 Europe Biosimilar Testing and Development Services Market Size by Type (2015-2020)
7.3 Europe Biosimilar Testing and Development Services Market Size by Application (2015-2020)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Biosimilar Testing and Development Services Market Size (2015-2026)
8.2 China Biosimilar Testing and Development Services Market Size by Type (2015-2020)
8.3 China Biosimilar Testing and Development Services Market Size by Application (2015-2020)
8.4 China Biosimilar Testing and Development Services Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Biosimilar Testing and Development Services Market Size (2015-2026)
9.2 Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020)
9.3 Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020)
9.4 Japan Biosimilar Testing and Development Services Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Biosimilar Testing and Development Services Market Size (2015-2026)
10.2 Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2015-2020)
10.3 Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2015-2020)
10.4 Southeast Asia Biosimilar Testing and Development Services Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2015-2020))
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2015-2020)
11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Effector Binding
Table 4. Key Players of ELISA
Table 5. Key Players of Kinetic Binding Assays
Table 6. Key Players of ADCC & CDC Cell-Based Assays
Table 7. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Biosimilar Testing and Development Services Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Biosimilar Testing and Development Services Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Biosimilar Testing and Development Services Market Share by Regions (2015-2020)
Table 11. Global Biosimilar Testing and Development Services Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Biosimilar Testing and Development Services Market Share by Regions (2021-2026)
Table 13. Biosimilar Testing and Development Services Market Market Trends
Table 14. Biosimilar Testing and Development Services Market Drivers
Table 15. Biosimilar Testing and Development Services Market Challenges
Table 16. Biosimilar Testing and Development Services Market Restraints
Table 17. Global Biosimilar Testing and Development Services Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Biosimilar Testing and Development Services Market Share by Players (2015-2020)
Table 19. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2019)
Table 20. Global Biosimilar Testing and Development Services by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosimilar Testing and Development Services Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Biosimilar Testing and Development Services Market Size Share by Type (2015-2020)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2021-2026)
Table 27. Global Biosimilar Testing and Development Services Market Size Share by Application (2015-2020)
Table 28. Global Biosimilar Testing and Development Services Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Biosimilar Testing and Development Services Market Size Share by Application (2021-2026)
Table 30. North America Biosimilar Testing and Development Services Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 32. North America Biosimilar Testing and Development Services Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 34. North America Biosimilar Testing and Development Services Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Biosimilar Testing and Development Services Market Share by Country (2015-2020)
Table 36. Europe Biosimilar Testing and Development Services Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 38. Europe Biosimilar Testing and Development Services Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 40. Europe Biosimilar Testing and Development Services Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Biosimilar Testing and Development Services Market Share by Country (2015-2020)
Table 42. China Biosimilar Testing and Development Services Market Size by Type (2015-2020) (US$ Million)
Table 43. China Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 44. China Biosimilar Testing and Development Services Market Size by Application (2015-2020) (US$ Million)
Table 45. China Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 46. China Biosimilar Testing and Development Services Market Size by Region (US$ Million) (2015-2020)
Table 47. China Biosimilar Testing and Development Services Market Share by Region (2015-2020)
Table 48. Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 50. Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 52. Japan Biosimilar Testing and Development Services Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Biosimilar Testing and Development Services Market Share by Country (2015-2020)
Table 54. Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 56. Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 58. Southeast Asia Biosimilar Testing and Development Services Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Biosimilar Testing and Development Services Market Share by Country (2015-2020)
Table 60. Eurofins Scientific Company Details
Table 61. Eurofins Scientific Business Overview
Table 62. Eurofins Scientific Product
Table 63. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 64. Eurofins Scientific Recent Development
Table 65. SGS Company Details
Table 66. SGS Business Overview
Table 67. SGS Product
Table 68. SGS Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 69. SGS Recent Development
Table 70. Charles River Laboratories Company Details
Table 71. Charles River Laboratories Business Overview
Table 72. Charles River Laboratories Product
Table 73. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 74. Charles River Laboratories Recent Development
Table 75. Pharmaceutical Product Development Company Details
Table 76. Pharmaceutical Product Development Business Overview
Table 77. Pharmaceutical Product Development Product
Table 78. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 79. Pharmaceutical Product Development Recent Development
Table 80. Exova Company Details
Table 81. Exova Business Overview
Table 82. Exova Product
Table 83. Exova Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 84. Exova Recent Development
Table 85. Source BioScience Company Details
Table 86. Source BioScience Business Overview
Table 87. Source BioScience Product
Table 88. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 89. Source BioScience Recent Development
Table 90. Intertek Group Company Details
Table 91. Intertek Group Business Overview
Table 92. Intertek Group Product
Table 93. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 94. Intertek Group Recent Development
Table 95. Medistri Business Overview
Table 96. Medistri Product
Table 97. Medistri Company Details
Table 98. Medistri Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 99. Medistri Recent Development
Table 100. Pace Analytical Services Company Details
Table 101. Pace Analytical Services Business Overview
Table 102. Pace Analytical Services Product
Table 103. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 104. Pace Analytical Services Recent Development
Table 105. Sigma-Aldrich Company Details
Table 106. Sigma-Aldrich Business Overview
Table 107. Sigma-Aldrich Product
Table 108. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2015-2020) (US$ Million)
Table 109. Sigma-Aldrich Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2020 VS 2026
Figure 2. Effector Binding Features
Figure 3. ELISA Features
Figure 4. Kinetic Binding Assays Features
Figure 5. ADCC & CDC Cell-Based Assays Features
Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2026
Figure 7. PK assay Case Studies
Figure 8. Tiered Immunogenicity testing Case Studies
Figure 9. NAb assays Case Studies
Figure 10. Biosimilar Testing and Development Services Report Years Considered
Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Biosimilar Testing and Development Services Market Share by Regions: 2020 VS 2026
Figure 13. Global Biosimilar Testing and Development Services Market Share by Regions (2021-2026)
Figure 14. Global Biosimilar Testing and Development Services Market Share by Players in 2019
Figure 15. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2019
Figure 17. North America Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 45. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 46. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 47. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 48. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 49. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 50. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 51. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 52. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 53. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed